Stocks · US
BIO
XNYS
Bio-Rad Laboratories, Inc.Class A
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E45.66x
P/B1.42x
P/S3.92x
EPS$8.32
ROE3.10%
ROA2.17%
Dividend yield0.00%
EV/EBITDA48.00x
Debt/Equity0.17
Free cash flow$353M
Returns and 52-week range
1W-2.82%
1M-4.48%
3M+29.93%
6M+32.67%
1Y+20.73%
YTD+20.82%
52W high$396.23
52W low$236.73
From 52W high-6.92%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| GLOBUS MEDICAL INC | $10.3B | 19.20 | 2.16 | -2.38% |
| 몰리나 헬스케어 | $10.1B | — | 2.43 | -2.80% |
| 유니버설 헬스 서비시스 | $10.4B | 6.80 | 1.38 | +4.38% |
| The Ensign Group, Inc. | $10.1B | 26.61 | 4.13 | +0.74% |
| Avantor, Inc. | $10.7B | — | 1.90 | +3.07% |
| 오스카 헬스 | $10.0B | 18.17 | 4.88 | +0.28% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.